GLYX 13 NEW

Rapastinel, also known as GLYX-13, is an innovative N-methyl-D-aspartate receptor (NMDAR) modulator that is unique in that it has certain agonist properties. This property enables Rapastinel to exhibit a more subtle and complex effect pattern when regulating NMDAR function, activating the receptor to produce the desired physiological response while also preventing the side effects that may be caused by excessive receptor activation to a certain extent, providing new possibilities for the treatment of a variety of neurological diseases.

Purchase process:

1. Contact the sales department to confirm the product name, quantity, price, packaging, etc.

2. After confirmation, remit the money to our company account and send detailed delivery information

3. Ship within 2 working days after payment and offer tracking number.

4. Customer confirms receipt

Rock

Whatsapp:+8618829283179

Email: rock@horlden.com